|
(-)-(5AS,10BR)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一水合物
|
|
|
- CAS号:
- 919102-70-8
- 英文名:
- Bode Catalyst 1
- 英文别名:
- 98.0%(LC);Bode Catalyst 1;Lacβ(1-4)Lac-β-C10>GUECWMLEUCWYOS-OZYANKIXSA-M;Neu5Acα(2-6)GalβMPGlycoside>GlcNAcβ(1-2)Manα-1-Ethylazide>Gal[2346Ac]β(1-3)GlcN3[46Bzd]-β-MP>3-(4-Nitrophenyl)-5-methyl-2-phenyltetrazolium Chloride >4-Methoxyphenyl2,6-Bis-O-(4-methylbenzoyl)-β-D-galactopyranoside>(1R,2R)-1,2-Bis(3,5-dimethylphenyl)-1,2-ethylenediamine Phosphate >
- 中文名:
- (-)-(5AS,10BR)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一水合物
- 中文别名:
- BODE 催化剂 1;3-(4-硝基苯基)-5-甲基-2-苯基氯化四氮唑(易制爆,甄准不供应);(5AS,10BR)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓;(5AS,10BR)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]恶嗪盐酸盐;(5AS,10BR)-5A,10B-二氢-2-(2,4,6-三甲苯基)-4H, 6H-茚并[2,1-B]-1,2,4-三唑并[4,3-D]-1,4-嗪氯化物;(-)-(5AS,10BR)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓;(-)-(5AS,10BR)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一水合物;(-)-(5AS,10BR)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一水合物,>98.0%(HPLC);(-)-(5AS,10BR)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一水合物;(-)-(5AS,10BR)-5A,10B-DIHYDRO-2-(2,4,6-TRIMETHYLPHENYL)-4H,6H-INDENO[2,1-B][1,2,4]TRIAZOLO[4,3-D][1,4]OXAZINIUM CHLORIDE MONOHYDRATE (-)-(5AS,10BR)-5A,10B-二氢-2-(2,4,6-三甲基苯基)-4H,6H-茚并[2,1-B][1,2,4]三唑[4,3-D][1,4]氯化恶唑鎓一水合物
- CBNumber:
- CB42098218
- 分子式:
- C21H22ClN3O
- 分子量:
- 367.88
- MOL File:
- 919102-70-8.mol
|